TrialClinical drug investigation2018

Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects.

Ramakrishna Nirogi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.